These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11920345)

  • 21. The Dialysis Outcome and Quality Initiative (DOQI) recommendations.
    Ascher E; Hingorani A
    Semin Vasc Surg; 2004 Mar; 17(1):3-9. PubMed ID: 15011173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of the Anemia Guidelines.
    DeOreo PB; Eschbach JW
    Adv Ren Replace Ther; 1999 Jan; 6(1):18-27. PubMed ID: 9925146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization, patency, and complications associated with vascular access for hemodialysis in the United States.
    Arhuidese IJ; Orandi BJ; Nejim B; Malas M
    J Vasc Surg; 2018 Oct; 68(4):1166-1174. PubMed ID: 30244924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of providers in implementation of the National Kidney Foundation-Dialysis Outcomes Quality Initiative: Fresenius Medical Care North America perspective.
    Lazarus JM; Wick G; Borella L
    Adv Ren Replace Ther; 1999 Jan; 6(1):59-66. PubMed ID: 9925151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of patients in the implementation of the National Kidney Foundation-Dialysis Outcomes Quality Initiative.
    Swartz MD; Robinson K; Davy T; Politoski G
    Adv Ren Replace Ther; 1999 Jan; 6(1):52-8. PubMed ID: 9925150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemoglobin variability in epoetin-treated hemodialysis patients.
    Berns JS; Elzein H; Lynn RI; Fishbane S; Meisels IS; Deoreo PB
    Kidney Int; 2003 Oct; 64(4):1514-21. PubMed ID: 12969173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron treatment: impact of safety issues.
    Fishbane S
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S152-6. PubMed ID: 9892383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of care for dialysis patients: national initiative focuses on improved treatment.
    Zarbock SF
    Home Care Provid; 1997 Apr; 2(2):62-3. PubMed ID: 9188324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing vascular access: a team perspective using the National Kidney Foundation-Dialysis Outcomes Quality Initiative Guidelines.
    Brouwer DJ
    Adv Ren Replace Ther; 1999 Jan; 6(1):93-6. PubMed ID: 9925156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful AV fistula creation does not lead to higher catheter use: the experience by the Northwest Renal Network 16 Vascular Access Quality Improvement Program. Four years follow-up.
    Nguyen VD; Griffith CN; Reus J; Barclay C; Alford S; Treat L; Hanthorn M; Ball L; Lawson L; Ledeen M; Buss J
    J Vasc Access; 2008; 9(4):260-8. PubMed ID: 19085896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving adequacy of hemodialysis in Northern California ESRD patients: a final project report. Provider Participants and Medical Review Board of the TransPacific Renal Network.
    Brown J; Josephson M
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S85-94. PubMed ID: 11053593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of the National Kidney Foundation-Dialysis Outcomes Quality Initiative Implementation.
    Eknoyan G; Levin NW
    Adv Ren Replace Ther; 1999 Jan; 6(1):3-6. PubMed ID: 9925143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation-Dialysis Outcomes Quality Initiative.
    Am J Kidney Dis; 1997 Oct; 30(4 Suppl 3):S150-91. PubMed ID: 9339150
    [No Abstract]   [Full Text] [Related]  

  • 34. National profile of practice patterns for hemodialysis vascular access in the United States.
    Reddan D; Klassen P; Frankenfield DL; Szczech L; Schwab S; Coladonato J; Rocco M; Lowrie EG; Owen WF;
    J Am Soc Nephrol; 2002 Aug; 13(8):2117-24. PubMed ID: 12138144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National Kidney Foundation: Dialysis Outcome Quality Initiative--development of methodology for clinical practice guidelines.
    Levin N; Eknoyan G; Pipp M; Steinberg E
    Nephrol Dial Transplant; 1997 Oct; 12(10):2060-3. PubMed ID: 9351065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethical and legal obligation to avoid long-term tunneled catheter access.
    Rehman R; Schmidt RJ; Moss AH
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):456-60. PubMed ID: 19158368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing an anemia management protocol. Case study of the anemic patient.
    Hossli S
    ANNA J; 1997 Dec; 24(6):678-84; quiz 685. PubMed ID: 9444110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval.
    Powe NR; Griffiths RI; de Lissovoy G; Anderson GF; Watson AJ; Greer JW; Herbert RJ; Eggers PW; Milam RA; Whelton PK
    JAMA; 1992 Sep; 268(11):1434-40. PubMed ID: 1512912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First hemodialysis access selection varies with patient acuity.
    Friedman AL; Walworth C; Meehan C; Wander H; Shemin D; DeSoi W; Kitsen J; Hill C; Lambert C; Mesler D
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S4-10. PubMed ID: 11053581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A journey in reversing practice patterns: a multidisciplinary experience in implementing DOQI guidelines for vascular access.
    Ackad A; Simonian GT; Steel K; Parisi C; Mancini S; Douglas C; Buckner D
    Nephrol Dial Transplant; 2005 Jul; 20(7):1450-5. PubMed ID: 15855211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.